FDA Clearance Tracker · P190002-S036
Saluda Medical Evoke SCS System
Last checked: Nov 20, 2026Latest source record: Jan 6, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Jan 6, 2026
Approved
Time to decision
344 days
Received Jan 27, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P190002-S036
- Device name
- Saluda Medical Evoke SCS System
- Applicant
- Saluda Medical Pty, Ltd.
- Applicant location
- Atarmon
- Received
- Jan 27, 2025
- Decided
- Jan 6, 2026
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P190002
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
approval for a manufacturing site located at Greatbatch Medical S. De R.L. De C.V., Calle 5 Norte No. 511 Ciudad, Industrial, Tijuana, Baja California, MX 22444, FEI: 3011823740 to manufacturer the Evoke Charger
Source documents
Other decisions for Saluda Medical Pty, Ltd.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Saluda Medical Evoke® SCS SystemPMA supplement
P190002-S019 · Decided Mar 20, 2024 · 180 days after receipt · Panel Track
Device type: Stimulator, spinal-cord, totally implanted for pain relief (LGW) · Neurology & Neurosurgery
1 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.